Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
Despite antiretroviral therapy (ART), some HIV-infected persons maintain lower than normal CD4(+) T-cell counts in peripheral blood and in the gut mucosa. This incomplete immune restoration is associated with higher levels of immune activation manifested by high systemic levels of biomarkers, includ...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb7c83c723e849f4957aae10ad49428d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:eb7c83c723e849f4957aae10ad49428d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:eb7c83c723e849f4957aae10ad49428d2021-11-18T06:07:03ZDecreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.1553-73661553-737410.1371/journal.ppat.1003890https://doaj.org/article/eb7c83c723e849f4957aae10ad49428d2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24497828/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Despite antiretroviral therapy (ART), some HIV-infected persons maintain lower than normal CD4(+) T-cell counts in peripheral blood and in the gut mucosa. This incomplete immune restoration is associated with higher levels of immune activation manifested by high systemic levels of biomarkers, including sCD14 and D-dimer, that are independent predictors of morbidity and mortality in HIV infection. In this 12-week, single-arm, open-label study, we tested the efficacy of IL-7 adjunctive therapy on T-cell reconstitution in peripheral blood and gut mucosa in 23 ART suppressed HIV-infected patients with incomplete CD4(+) T-cell recovery, using one cycle (consisting of three subcutaneous injections) of recombinant human IL-7 (r-hIL-7) at 20 µg/kg. IL-7 administration led to increases of both CD4(+) and CD8(+) T-cells in peripheral blood, and importantly an expansion of T-cells expressing the gut homing integrin α4β7. Participants who underwent rectosigmoid biopsies at study baseline and after treatment had T-cell increases in the gut mucosa measured by both flow cytometry and immunohistochemistry. IL-7 therapy also resulted in apparent improvement in gut barrier integrity as measured by decreased neutrophil infiltration in the rectosigmoid lamina propria 12 weeks after IL-7 administration. This was also accompanied by decreased TNF and increased FOXP3 expression in the lamina propria. Plasma levels of sCD14 and D-dimer, indicative of systemic inflammation, decreased after r-hIL-7. Increases of colonic mucosal T-cells correlated strongly with the decreased systemic levels of sCD14, the LPS coreceptor - a marker of monocyte activation. Furthermore, the proportion of inflammatory monocytes expressing CCR2 was decreased, as was the basal IL-1β production of peripheral blood monocytes. These data suggest that administration of r-hIL-7 improves the gut mucosal abnormalities of chronic HIV infection and attenuates the systemic inflammatory and coagulation abnormalities that have been linked to it.Irini SeretiJacob D EstesWilliam L ThompsonDavid R MorcockMargaret A FischlThérèse CroughsStéphanie BeqSylvie Lafaye de MicheauxMichael D YaoAlexander OberEleanor M P WilsonVen NatarajanHiromi ImamichiMohamed R BoulasselMichael M LedermanJean-Pierre RoutyPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 10, Iss 1, p e1003890 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Irini Sereti Jacob D Estes William L Thompson David R Morcock Margaret A Fischl Thérèse Croughs Stéphanie Beq Sylvie Lafaye de Micheaux Michael D Yao Alexander Ober Eleanor M P Wilson Ven Natarajan Hiromi Imamichi Mohamed R Boulassel Michael M Lederman Jean-Pierre Routy Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. |
description |
Despite antiretroviral therapy (ART), some HIV-infected persons maintain lower than normal CD4(+) T-cell counts in peripheral blood and in the gut mucosa. This incomplete immune restoration is associated with higher levels of immune activation manifested by high systemic levels of biomarkers, including sCD14 and D-dimer, that are independent predictors of morbidity and mortality in HIV infection. In this 12-week, single-arm, open-label study, we tested the efficacy of IL-7 adjunctive therapy on T-cell reconstitution in peripheral blood and gut mucosa in 23 ART suppressed HIV-infected patients with incomplete CD4(+) T-cell recovery, using one cycle (consisting of three subcutaneous injections) of recombinant human IL-7 (r-hIL-7) at 20 µg/kg. IL-7 administration led to increases of both CD4(+) and CD8(+) T-cells in peripheral blood, and importantly an expansion of T-cells expressing the gut homing integrin α4β7. Participants who underwent rectosigmoid biopsies at study baseline and after treatment had T-cell increases in the gut mucosa measured by both flow cytometry and immunohistochemistry. IL-7 therapy also resulted in apparent improvement in gut barrier integrity as measured by decreased neutrophil infiltration in the rectosigmoid lamina propria 12 weeks after IL-7 administration. This was also accompanied by decreased TNF and increased FOXP3 expression in the lamina propria. Plasma levels of sCD14 and D-dimer, indicative of systemic inflammation, decreased after r-hIL-7. Increases of colonic mucosal T-cells correlated strongly with the decreased systemic levels of sCD14, the LPS coreceptor - a marker of monocyte activation. Furthermore, the proportion of inflammatory monocytes expressing CCR2 was decreased, as was the basal IL-1β production of peripheral blood monocytes. These data suggest that administration of r-hIL-7 improves the gut mucosal abnormalities of chronic HIV infection and attenuates the systemic inflammatory and coagulation abnormalities that have been linked to it. |
format |
article |
author |
Irini Sereti Jacob D Estes William L Thompson David R Morcock Margaret A Fischl Thérèse Croughs Stéphanie Beq Sylvie Lafaye de Micheaux Michael D Yao Alexander Ober Eleanor M P Wilson Ven Natarajan Hiromi Imamichi Mohamed R Boulassel Michael M Lederman Jean-Pierre Routy |
author_facet |
Irini Sereti Jacob D Estes William L Thompson David R Morcock Margaret A Fischl Thérèse Croughs Stéphanie Beq Sylvie Lafaye de Micheaux Michael D Yao Alexander Ober Eleanor M P Wilson Ven Natarajan Hiromi Imamichi Mohamed R Boulassel Michael M Lederman Jean-Pierre Routy |
author_sort |
Irini Sereti |
title |
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. |
title_short |
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. |
title_full |
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. |
title_fullStr |
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. |
title_full_unstemmed |
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. |
title_sort |
decreases in colonic and systemic inflammation in chronic hiv infection after il-7 administration. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/eb7c83c723e849f4957aae10ad49428d |
work_keys_str_mv |
AT irinisereti decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT jacobdestes decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT williamlthompson decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT davidrmorcock decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT margaretafischl decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT theresecroughs decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT stephaniebeq decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT sylvielafayedemicheaux decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT michaeldyao decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT alexanderober decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT eleanormpwilson decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT vennatarajan decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT hiromiimamichi decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT mohamedrboulassel decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT michaelmlederman decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration AT jeanpierrerouty decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration |
_version_ |
1718424574136156160 |